Your browser doesn't support javascript.
loading
A new hope: Mitochondria, a critical factor in the war against prions.
Zambrano, Kevin; Barba, Diego; Castillo, Karina; Robayo, Paola; Arizaga, Eduardo; Caicedo, Andrés; Gavilanes, Antonio W D.
Afiliação
  • Zambrano K; Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841 Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, 17-12-841 Quito, Ecuador; School for Mental Health and Neuroscience (MHeNs), Maastric
  • Barba D; Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841 Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, 17-12-841 Quito, Ecuador; Mito-Act Research Consortium, Quito, Ecuador.
  • Castillo K; Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841 Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, 17-12-841 Quito, Ecuador; Mito-Act Research Consortium, Quito, Ecuador.
  • Robayo P; Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841 Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, 17-12-841 Quito, Ecuador; Mito-Act Research Consortium, Quito, Ecuador.
  • Arizaga E; Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841 Quito, Ecuador.
  • Caicedo A; Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841 Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, 17-12-841 Quito, Ecuador; Mito-Act Research Consortium, Quito, Ecuador; Sistemas Médi
  • Gavilanes AWD; School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, The Netherlands. Electronic address: danilo.gavilanes@mumc.nl.
Mitochondrion ; 65: 113-123, 2022 07.
Article em En | MEDLINE | ID: mdl-35623560
Prion diseases encompass a group of incurable neurodegenerative disorders that occur due to the misfolding and aggregation of infectious proteins. The most well-known prion diseases are Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy (also known as mad cow disease), and kuru. It is estimated that around 1-2 persons per million worldwide are affected annually by prion disorders. Infectious prion proteins propagate in the brain, clustering in the cells and rapidly inducing tissue degeneration and death. Prion disease alters cell metabolism and energy production damaging mitochondrial function and dynamics leading to a fast accumulation of damage. Dysfunction of mitochondria could be considered as an early precursor and central element in the pathogenesis of prion diseases such as in sporadic CJD. Preserving mitochondria function may help to resist the rapid spread and damage of prion proteins and even clearance. In the war against prions and other degenerative diseases, studying how to preserve the function of mitochondria by using antioxidants and even replacing them with artificial mitochondrial transfer/transplant (AMT/T) may bring a new hope and lead to an increase in patients' survival. In this perspective review, we provide key insights about the relationship between the progression of prion disease and mitochondria, in which understanding how protecting mitochondria function and viability by using antioxidants or AMT/T may help to develop novel therapeutic interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Príons / Encefalopatia Espongiforme Bovina / Doenças Priônicas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Príons / Encefalopatia Espongiforme Bovina / Doenças Priônicas Idioma: En Ano de publicação: 2022 Tipo de documento: Article